Get the Stockscreener App
9.63
0.31%
0.03
After Hours:
9.63
Inogen Inc stock is traded at $9.63, with a volume of 122.02K.
It is up +0.31% in the last 24 hours and up +4.33% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$9.60
Open:
$9.72
24h Volume:
122.02K
Relative Volume:
0.65
Market Cap:
$234.73M
Revenue:
$315.66M
Net Income/Loss:
$-102.45M
P/E Ratio:
-2.2983
EPS:
-4.19
Net Cash Flow:
$-30.25M
1W Performance:
+1.80%
1M Performance:
+4.33%
6M Performance:
+9.31%
1Y Performance:
+63.78%
1-Day Range:
$9.54
$9.93
1-Week Range:
$8.71
$9.93
52-Week Range:
$4.93
$13.33
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
9.63 | 234.73M | 315.66M | -102.45M | -30.25M | -4.19 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
INGN (Inogen) Earnings per Share (Diluted) : $-2.25 (TTM As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Buys 132,287 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Inogen (NASDAQ:INGN) Stock Rating Lowered by StockNews.com - Defense World
Brown Capital Management LLC Reduces Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - MSN
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up - MSN
Short Interest in Inogen, Inc. (NASDAQ:INGN) Decreases By 11.4% - MarketBeat
Inogen, Inc. (NASDAQ:INGN) Q3 2024 Earnings Call Transcript - Insider Monkey
US$10.00That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results - Yahoo Finance
Inogen (NASDAQ:INGN) soars 28% this week, taking one-year gains to 129% - Simply Wall St
Inogen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Inogen Inc (INGN) Quarterly 10-Q Report - Quartzy
Inogen (NASDAQ:INGN) Earns "Hold" Rating from Needham & Company LLC - MarketBeat
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates - MSN
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B G - GuruFocus.com
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges By GuruFocus - Investing.com Canada
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges - Yahoo Finance Australia
Inogen, Inc. Reports Third Quarter 2024 Financial Results - TipRanks
Inogen Inc earnings beat by $0.25, revenue topped estimates - Investing.com Canada
Inogen: Q3 Earnings Snapshot - San Antonio Express-News
Inogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Inogen Announces Third Quarter 2024 Financial Results - The Bakersfield Californian
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Inogen, Inc. (INGN): A Bear Case Theory - Insider Monkey
Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expec - GuruFocus.com
Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: TytoCare Ltd., Inogen, Inc., - EIN News
Inogen to Present at Upcoming Investor Conferences - sharewise
9 Best Portable Oxygen Concentrators in November 2024: Our Expert Picks - National Council on Aging
INGNInogen Inc Latest Stock News & Market Updates - StockTitan
Inogen (NASDAQ:INGN) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Inogen (INGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Inogen Debuts Rove 4 Portable Oxygen Concentrator - MPO-mag
Inogen (NASDAQ:INGN) Stock Price Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 - The Bakersfield Californian
Sanctuary Advisors LLC Acquires Shares of 80,075 Inogen, Inc. (NASDAQ:INGN) - Defense World
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: Medtronic, Inogen, Inc, ICU - EIN News
Oxygen Concentrators Market Driving Innovation: The Role - openPR
80,075 Shares in Inogen, Inc. (NASDAQ:INGN) Acquired by Sanctuary Advisors LLC - MarketBeat
Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges - Yahoo Finance
Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges By GuruFocus - Investing.com Canada
Respiratory Care Market Poised for Significant Growth from 2024 to 2031: Hamilton Medical, TytoCare Ltd., - EIN News
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC - sharewise
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting Poc - Marketscreener.com
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally? - MSN
Marshall Wace LLP Cuts Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Somer Jason | EVP, Gen. Counsel & Secretary |
Jun 01 '24 |
Option Exercise |
0.00 |
577 |
0 |
5,029 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
May 10 '24 |
Sale |
8.56 |
10,000 |
85,600 |
4,452 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
May 01 '24 |
Option Exercise |
0.00 |
19,276 |
0 |
25,764 |
| Glezer Stanislav | EVP, R&D & Chief Med. Officer |
May 01 '24 |
Option Exercise |
0.00 |
32,638 |
0 |
48,744 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
Mar 01 '24 |
Option Exercise |
0.00 |
7,150 |
0 |
11,064 |
| Glezer Stanislav | EVP, R&D & Chief Med. Officer |
Mar 01 '24 |
Option Exercise |
0.00 |
13,914 |
0 |
23,729 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
Dec 01 '23 |
Option Exercise |
0.00 |
576 |
0 |
4,200 |
| Glezer Stanislav | EVP, Chief Technology Officer |
Dec 01 '23 |
Option Exercise |
0.00 |
4,555 |
0 |
12,146 |
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):